Francesco Guida

No ORCID on file · 1 paper in corpus
review 2019
Oncotarget ·doi:10.18632/oncotarget.26803

Gynaecological sarcomas account for 3-4% of all gynaecological malignancies and have a poorer prognosis compared to gynaecological carcinomas. Pivotal treatment for early-stage uterine sarcoma is represented by total hysterectomy. Whereas o…